We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

  BÜBL™ WINS BRONZE LION This year, Osteoporosis Canada launched a transformative campaign intended to disrupt the osteoporosis landscape, while shining a light on a disease that affects 2 million […]

SAC Members and Research MD, MSC, PHD AhmedNegm Dr. Ahmed Negm is a trained orthopedic surgeon with additional training in health research and rehabilitation sciences. Following his undergraduate medical training […]

On behalf of Osteoporosis Canada’s Scientific Advisory Consultants and Osteoporosis Canada, we would like to announce this year’s Lindy Fraser Award winner as chosen by the members of the SAC. […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

SAC Members and Research MD, PHD LaetitiaMichou Dr. Michou has completed her medicine studies at the University of Angers (France), her Rheumatology residency at the Denis Diderot-Paris VII University (France) […]

No one likes to think about emergency planning but 57% of Canadian adults don’t have a will, and that number goes up to 89% among millennials. Having a solid estate […]

St. Clare’s Mercy Hospital in Newfoundland and Labrador St. Clare’s Mercy Hospital in Newfoundland and Labrador Breakfree Fracture Liaison Service (FLS) established in March 2024 New Breakfree Fracture Liaison Service […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]